These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. Sakaguchi A; Kikuchi A J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935 [TBL] [Abstract][Full Text] [Related]
3. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing. Yu Q; Mirski SE; Sparks KE; Cole SP Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428 [TBL] [Abstract][Full Text] [Related]
4. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo. Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531 [TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis. Hammonds TR; Foster SR; Maxwell A J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345 [TBL] [Abstract][Full Text] [Related]
6. Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis. Null AP; Hudson J; Gorbsky GJ Cell Growth Differ; 2002 Jul; 13(7):325-33. PubMed ID: 12133901 [TBL] [Abstract][Full Text] [Related]
7. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells. Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432 [TBL] [Abstract][Full Text] [Related]
8. Catalytic function of DNA topoisomerase II. Osheroff N; Zechiedrich EL; Gale KC Bioessays; 1991 Jun; 13(6):269-73. PubMed ID: 1654050 [TBL] [Abstract][Full Text] [Related]
9. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity. Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites. Lok CN; Lang AJ; Mirski SE; Cole SP Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834 [TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide. Sengupta T; Mukherjee M; Das A; Mandal C; Das R; Mukherjee T; Majumder HK Biochem J; 2005 Sep; 390(Pt 2):419-26. PubMed ID: 15901238 [TBL] [Abstract][Full Text] [Related]
13. Chlorella virus Marburg topoisomerase II: high DNA cleavage activity as a characteristic of Chlorella virus type II enzymes. Dickey JS; Choi TJ; Van Etten JL; Osheroff N Biochemistry; 2005 Mar; 44(10):3899-908. PubMed ID: 15751965 [TBL] [Abstract][Full Text] [Related]
14. An atypical topoisomerase II from Archaea with implications for meiotic recombination. Bergerat A; de Massy B; Gadelle D; Varoutas PC; Nicolas A; Forterre P Nature; 1997 Mar; 386(6623):414-7. PubMed ID: 9121560 [TBL] [Abstract][Full Text] [Related]
15. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast. Sakaguchi A; Akashi T; Kikuchi A Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066 [TBL] [Abstract][Full Text] [Related]
16. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity. Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921 [TBL] [Abstract][Full Text] [Related]
17. A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus. Kondapi AK; Padmaja G; Satyanarayana N; Mukhopadyaya R; Reitz MS Arch Biochem Biophys; 2005 Sep; 441(1):41-55. PubMed ID: 16091284 [TBL] [Abstract][Full Text] [Related]
18. Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways. Mandraju RK; Kondapi AK Arch Biochem Biophys; 2007 May; 461(1):40-9. PubMed ID: 17391642 [TBL] [Abstract][Full Text] [Related]
19. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance. Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602 [TBL] [Abstract][Full Text] [Related]
20. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes. Kondapi AK; Satyanarayana N; Saikrishna AD Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]